Related Experiment Video
Updated: May 26, 2026
Establishing a Device for Sleep Deprivation in Mice
Published on: September 22, 2023
Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction
Karim Zouaoui Boudjeltia1, Brice Faraut, Maria José Esposito
1Laboratory of Experimental Medicine, Centre Hospitalo-Universitaire de Charleroi, André Vésale Hospital, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Objectives:
Many studies have evaluated the ways in which sleep disturbances may influence inflammation and the possible links of this effect to cardiovascular risk. Our objective was to investigate the effects of chronic sleep restriction and recovery on several blood cardiovascular biomarkers.
Methods And Results:
Nine healthy male non-smokers, aged 22-29 years, were admitted to the Sleep Laboratory for 11 days and nights under continuous electroencephalogram polysomnography. The study consisted of three baseline nights of 8 hours sleep (from 11 pm to 7 am), five sleep-restricted nights, during which sleep was allowed only between 1 am and 6 am, and three recovery nights of 8 hours sleep (11 pm to 7 am). Myeloperoxidase-modified low-density lipoprotein levels increased during the sleep-restricted period indicating an oxidative stress. A significant increase in the quantity of slow-wave sleep was measured during the first recovery night. After this first recovery night, insulin-like growth factor-1 levels increased and myeloperoxidase concentration peaked.
Conclusions:
We observed for the first time that sleep restriction and the recovery process are associated with differential changes in blood biomarkers of cardiovascular disease.
